RICERCA ITALIANA     

Programmi di ricerca simili:

• 1 - Nuovi vaccini e basi epidemiologiche per la loro applicazione
• 2 - Infezioni respiratorie: epidemiologia molecolare, cross-protection e impatto delle strategie preventive
• 3 - Un modello integrato di valutazione e gestione del rischio di Infezione Tubercolare e di Tubercolosi in fase attiva in popolazioni socialmente disagiate ("homeless") nella città di Roma.
• 4 - Definizione del profilo epidemiologico delle gastroenteriti virali nella prospettiva dell'introduzione di nuove vaccinazioni
• 5 - Epidemiologia e nuove prospettive di prevenzione delle infezioni respiratorie acute
• 6 - Eziopatogenesi del sarcoma di Kaposi: ruolo dello Human Herpesvirus 8 e di altri co-fattori potenzialmente coinvolti.
• 7 - Approccio integrato al riconoscimento di taxa problematici della meiofauna marina: realizzazione di volumi della serie "Fauna d'Italia" e sviluppo e valutazione di tecniche di DNA-barcoding per l'identificazione di Gastrotrichi, Proseriati e Rotiferi
• 8 - Epidemiologia, Sorveglianza e Nuove Prospettive di Prevenzione di Morbillo, Rosolia e Parotite
• 9 - Approcci vaccinali innovativi per il controllo delle infezioni erpetiche e papillomatose sessualmente trasmesse
• 10 - Strategie vaccinali e modelli matematici.

Classificazione scientifico-disciplinare

• Area scientifico disciplinare: Scienze mediche
  • MICROBIOLOGIA E MICROBIOLOGIA CLINICA
  • MALATTIE INFETTIVE
  • NEUROLOGIA
  • PEDIATRIA GENERALE E SPECIALISTICA
  • IGIENE GENERALE E APPLICATA

Classificazione brevettuale

• HUMAN NECESSITIES
  • AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES, AS HERBICIDES (preparations for medical, dental or toilet purposes A61K; methods or apparatus for disinfection or sterilisation in general, or for deodorising of air A61L); PEST REPELLANTS OR ATTRACTANTS (decoys A01M1/06; medicinal preparations A61K); PLANT GROWTH REGULATORS (compounds in general C01, C07, C08; fertilisers C05; soil conditioners or stabilisers C09K17/00) [C9908]
  • FURNITURE (arrangements of seats for, or adaptations of seats to, vehicles B60N); DOMESTIC ARTICLES OR APPLIANCES; COFFEE MILLS; SPICE MILLS; SUCTION CLEANERS IN GENERAL (ladders E06C)
    • FURNITURE SPECIALLY ADAPTED FOR CHILDREN (school benches or desks A47B39/00, A47B41/00)
• PHYSICS
  • SIGNALLING (indicating or display devices per se G09F; transmission of pictures H04N) [C9504]
    • SIGNALLING OR CALLING SYSTEMS; ORDER TELEGRAPHS; ALARM SYSTEMS (signalling arrangements on vehicles B60Q, B62D41/00; railway signalling systems or devices B61L; on cycles B62J3/00, B62J6/00; safes or strong-rooms with alarm devices E05G; signalling or alarm devices in mines E21F17/18; lamps or shutters therefor F21; sensitive measuring elements, see the appropriate subclasses of G01; traffic control systems G08G; visual indicating means G09; sound-producing devices G10; radio or near-field calling systems H04B5/00, H04B7/00; selecting arrangements H04Q7/00, H04Q9/00; loudspeakers, microphones, gramophone pick-ups or like acoustic electromechanical transducers H04R) [C9504]

Classificazione geografica

• Regione: Lazio

Bibliografia

Abbink F, Buisman AM, Doornbos et al. Poliovirus-Specific Memory Immunity in Seronegative Elderly People Does Not Protect against Virus Excretion. J Infect Dis. 2005 Mar 15;191(6):990-9.

Adu FD, Kembi FA, Bamgboye A, et al. Wild polio virus surveillance in the sewage system of selected communities at the risk of poliomyelitis in southwest Nigeria. East Afr Med J. 1998 ;75(2):97-9

Blomqvist S, Bruu AL, Stenvik M, et al. Characterization of a recombinant type 3/type 2 poliovirus isolated from a healthy vaccinee and containing a chimeric capsid protein VP1. J Gen Virol. 2003; 84: 573-80.

Bottiger M, Herrstrom E. Isolation of polioviruses from sewage and their characteristics: experience over two decades in Sweden. Scand J Infect Dis 1992; 24: 151-155

Buttinelli G, Donati V, Fiore S, et al. Nucleotide variation in Sabin type 2 poliovirus from an immunodeficient patient with poliomyelitis. J Gen Virol 2003; 84: 1215-21.

CDC - Global Polio Eradication Initiative Strategic Plan, 2004. MMWR Morb Mortal Wkly Rep. 2004;53(5):107-8.

CDC - Progress toward poliomyelitis eradication--Nigeria, January 2000-March 2002. MMWR 51(22):479-81

CDC Imported wild poliovirus causing poliomyelitis. Bulgaria, 2001. MMWR 2001; 50:1033-5.

CDC. Acute flaccid paralysis associated with circulating vaccine-derived polioviruses. Philippines, 2001 MMWR 2001; 50:874-5

CDC. Apparent global interruption of wild poliovirus type 2 transmission. MMWR 2001; 50: 222-4.

CDC. Outbreak of poliomyelitis. Dominican Republic and Haiti, 2000-2001. JAMA 2001;286(22):2802.

Certification of poliomyelitis eradication--European Region, June 2002. MMWR 2002 Jul 5;51(26):572-4.

Certification of poliomyelitis eradication--the Americas, 1994. MMWR 1994; 43(39):720-2.

Certification of poliomyelitis eradication--Western Pacific Region, October 2000. MMWR 2001;50(1):1-3.

Cherkasova EA, Korotkova EA, Yakovenko ML, et al. Long-term circulation of vaccine-derived poliovirus that causes paralytic disease. J Virol 2002; 76 (13): 6791-9.

Cuervo NS, Guillot S, Romanenkova N et al. Genomic features of intertypic recombinant sabin poliovirus strains excreted by primary vaccinees. J Virol 2001; 75 (13): 5740-51.

Dahourou G, Guillot S, Le Gall O, Crainic R. Genetic recombination in wild-type poliovirus. J Gen Virol 2002 ; 83: 3103-10.

Deshpande JM, Nadkarni SS, Siddiqui ZA. Detection of MEF-1 laboratory reference strain of poliovirus type 2 in children with poliomyelitis in India in 2002 & 2003. Indian J Med Res 2003; 118: 217-23.

Fiore L, Novello F, Simeoni P et al. Surveillance of acute flaccid paralysis in Italy: 1996-97. Eur J Epidemiol 1999

Fleck F. Polio eradication: 7 countries and US$ 210 million to go. Bull World Health Organ. 2003;81(9):696-7

Georgescu MM, Balanant J, Macadam A, et al. Sabin type 2 polioviruses with intertypic vaccine/vaccine recombinant genomes. Eur J Clin Microbiol Infect Dis. 2001; 20(11):792-9.

Global Polio Eradication Initiative, strategic plan 2004-2008. Wkly Epidemiol Rec. 2004;79(6):55-7

Grabow WO, Botma KL, de Villiers JC, et al. Assessment of cell culture and polymerase chain reaction procedures for the detection of polioviruses in wastewater. Bull World Health Organ. 1999;77(12):973-80

Guillot S, Caro V, Cuervo N, et al. Natural genetic exchanges between vaccine and wild poliovirus strains in humans. J Virol 2000; 74(18): 8434-43.

John TJ. The golden jubilee of vaccination against poliomyelitis. Indian J Med Res. 2004;119:1-17.

Kew O, Morris Glasgow V, Landaverde M et al. Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Science. 2002;296(5566):356-9.

Khetsuriani N, Prevots DR, Quick L, et al. Persistence of vaccine-derived polioviruses among immunodeficient persons with vaccine-associated paralytic poliomyelitis. J Infect Dis. 2003; 188(12): 1845-52.

Kilpatrick DR, Nottay B, Yang CF, et al. Serotype-specific identification of polioviruses by PCR using primers containing mixed-base or deoxyinosine residues at positions of codon degeneracy. J Clin Microbiol 1998;36:352-357.

Knolle H, Egli A, Candrian U. The perspective of global eradication of poliomyelitis Gesundheitswesen. 2004; 66(1): 1-6.

Knolle H. Transmission of poliomyelitis by drinking water and the problem of prevention. Gesundheitswesen. 1995;57 (6):351-4.

Kohara M, Abe S, Komatsu T, et al. A recombinant virus between the Sabin 1 and Sabin 3 vaccine strains of poliovirus as a possible candidate for a new type 3 poliovirus live vaccine strain. J Virol 1988 Aug; 62 (8): 2828-35.

Lipskaya GY, Muzychenko AR, Kutitova OK, et al.Frequent isolation of intertypic poliovirus recombinants with serotype 2 specificity from vaccine-associated polio cases. J Med Virol 1991; 35 (4): 290-6.

Macadam AJ, Arnold C, Howlett J, et al. Reversion of the attenuated and temperature-sensitive phenotypes of the Sabin type 3 strain of poliovirus in vaccinees. Virology 1989; 172 (2): 408-14.

Manor Y, Handsher R, Halmut T, et al Detection of poliovirus circulation by environmental surveillance in the absence of clinical cases in Israel and the Palestinian authority. J Clin Microbiol 1999; 37: 1670-1675

Matsuura K, Ishikura M, Yoshida H, et al.Assessment of poliovirus eradication in Japan: genomic analysis of polioviruses isolated from river water and sewage in Toyama prefecture. Appl Environ Microbiol. 2000 Nov; 66 (11): 5087-91.

Novello F, Lombardi F, Amato C. et al. Paralytic poliomyelitis in Italy. (1981-85). Eur J Epidemiol 1987; 3:54-60.

Pincock S. Poliovirus spreads beyond Nigeria after vaccine uptake drops. BMJ. 2004 Feb 7; 328 (7435):310.

Poliomyelitis-eradication initiative's wider lessons. Lancet. 2004 Jan 10; 363(9403): 93.

Samba E, Nkrumah F, Leke R. Getting polio eradication back on track in Nigeria. N Engl J Med 2004 Feb 12; 350(7): 645-6.

Shulman LM, Handsher R, Yang CF, et al. Resolution of the pathways of poliovirus type 1 transmission during an outbreak. J Clin Microbiol. 2000 Mar; 38(3):945-52.

Singh MM. Polio eradication in India need for a humane approach. J Commun Dis. 2002; 34(3): 230-1.

Soares C. Polio postponed. Politics slow polio's eradication and cause it to spread. Sci Am. 2005 Jan;292(1):8-9.

Tulchinsky TH. Polio eradication: end-stage challenges.Bull World Health Organ. 2005 Feb;83(2):160.

van der Avoort HG, Hull BP, Hovi T, et al. Comparative study of five methods for intratypic differentiation of polioviruses. J Clin Microbiol 1995; 33:2562-2566.

WHO Department of Vaccines and Biologicals. World Health Organization global action plan for laboratory containment of wild polioviruses. Geneva, Switzerland: World Health Organization, 1999 (Reference WHO/V&B/99.32).

WHO Technical Consultative Group to the World Health Organization on the Global Eradication of Poliomyelitis. "Endgame" issues for the global polio eradication initiative. Clin Infect Dis 2002;34:72-7.

World Health Assembly. Polio eradication by the year 2000. Resolutions of the 41st World Health Assembly. Geneva, Switzerland: World Health Organization, 1988 (Resolution 41.28).

World Health Organization. Expanded programme on immunisation. Manual for the Virological Investigation of Poliomyelitis. Geneva: WHO publication n. WHO/EPI/GEN/ 97.O1.

World Health Organization. Progress towards poliomyelitis eradication poliomyelitis outbreak in Sudan,2004.Wkly Epidemiol Rec. 2005 Feb 4;80(5):42-6.
Wyatt HV. Polio eradication in India: some queries. Natl Med J India 2003 Nov-Dec; 16(6): 340-2

Yoshida H, Horie H, Matsuura K, et al.Prevalence of vaccine-derived polioviruses in the environment. J Gen Virol. 2002 May;83:1107-11

Zarocostas J. Polio-endemic countries pledge to boost eradication efforts in 2004. But whether the disease can be eradicated will depend on situation in Nigeria. Lancet. 2004; 363(9404): 215.

Parole Chiave

POLIOMIELITE; ERADICAZIONE; SORVEGLIANZA; VACCINAZIONE; POLIOVIRUS SELVAGGIO; SABIN LIKE; VDPV; LIQUAMI; CARRIER